Diagnostic accuracy of novel scoring systems using serum biomarkers for nonalcoholic steatohepatitis (NASH) - Trial UMIN000018158

Name: Clinical Trial UMIN000018158
Creator: Saiseikai Suita Hospital
Keywords: Nonalcoholic fatty liver disease (NAFLD), Not Applicable, clinical trial, Japan

Access comprehensive clinical trial information for UMIN000018158 through Pure Global AI's free database. This Not Applicable trial is sponsored by Saiseikai Suita Hospital and is currently Completed. The study focuses on Nonalcoholic fatty liver disease (NAFLD).

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database

840K+ Trials

UMIN000018158

Not Applicable

Completed

Trial Details

University Hospital Medical Information Network • UMIN000018158

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Diagnostic accuracy of novel scoring systems using serum biomarkers for nonalcoholic steatohepatitis (NASH)

Study Focus

Disease/Condition

Nonalcoholic fatty liver disease (NAFLD)

Study Type

Observational

Sponsor & Location

Primary Sponsor

Saiseikai Suita Hospital

Location

Japan

Timeline & Enrollment

Phase

Not Applicable

Start Date

Jul 21, 2015

End Date

N/A

ICD-10 Classifications

Liver disease, unspecified

Inflammatory liver disease, unspecified

Alcoholic liver disease, unspecified

Alcoholic fatty liver

Toxic liver disease, unspecified

Data Source

Registry

University Hospital Medical Information Network

Trial ID

UMIN000018158

Type

Non-Device Trial